SCHEMBL4855130

SCHEMBL4855130

Cc1ccc(OCCN(C)C)c(C=CC(=O)c2ccccc2OCCN(C)C)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 1/20 0.47
KDM4E B2RXH2 6/20 0.46
GAA P10253 1/20 0.46
MAPT P10636 4/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
LMNA P02545 3/20 0.46
TDP1 Q9NUW8 3/20 0.46
HSP90AA1 P07900 3/20 0.46
HTT P42858 3/20 0.46
NPSR1 Q6W5P4 2/20 0.46
ALDH1A1 P00352 2/20 0.46
MEN1 O00255 2/20 0.46
POLB P06746 2/20 0.46
KMT2A Q03164 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
BCHE P06276 2/20 0.45
ACHE P22303 2/20 0.45
HRH1 P35367 1/20 0.45
ABCG2 Q9UNQ0 1/20 0.44
AR P10275 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4855122 0.91 AR (0.48) KDM4EGAAMAPTSMN1; SMN2LMNA
SCHEMBL4856553 0.91 AR (0.48) KDM4EGAAMAPTSMN1; SMN2LMNA
SCHEMBL4852994 0.89 PTGER1 (0.45) ABCB1KDM4EGAAMAPTSMN1; SMN2
SCHEMBL4849810 0.88 ABCB1 (0.43) ABCB1KDM4ESMN1; SMN2ALDH1A1BCHE
SCHEMBL4849710 0.85 SYK (0.42) ABCB1KDM4ESMN1; SMN2ALDH1A1BCHE
SCHEMBL4853942 0.85 AR (0.45) ABCB1KDM4EMAPTSMN1; SMN2LMNA
SCHEMBL4856370 0.84 PDE4A (0.62) KDM4EGAAMAPTSMN1; SMN2LMNA
SCHEMBL4848288 0.84 AR (0.41) ABCB1KDM4EMAPTSMN1; SMN2LMNA
SCHEMBL4852990 0.84 PTGER1 (0.44) KDM4EGAATDP1ALDH1A1BCHE
SCHEMBL4856430 0.84 PTGER1 (0.44) KDM4EGAATDP1ALDH1A1BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed